FDA recommends States Pause use of J&J Covid Vaccine after rare blood-clotting issue affects 6 women, kills 1

</p> <h2>US States to Halt Rollout</h2> <p> The FDA is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood-clotting disorder.<br /> The FDA said the recommendation is “out of an abundance of caution.”<br /> The cases occurred in women ages 18 to 48, with symptoms developing six to 13 days after they received the shot.<br />  <br /> Credit to : cnbc</p> <p>